Grant Thomas Rawlin

Title: Grant Thomas Rawlin: Innovator in Enteric Disease Treatment

Introduction

Grant Thomas Rawlin is a notable inventor based in Kilmore East, Australia. He has made significant contributions to the field of medical science, particularly in the treatment and prevention of enteric bacterial infections. With a total of 2 patents, Rawlin's work focuses on innovative methods to combat diseases caused by Gram-negative bacteria.

Latest Patents

Rawlin's latest patents include a composition and method for the treatment and prevention of enteric bacterial infections. This invention provides a method of treatment or prophylaxis for enteric diseases caused by Gram-negative bacteria. The method involves administering a vaccine or hyperimmune material raised against the vaccine to an individual. The vaccine comprises one or more cell wall antigens that are reactive in a manner characteristic of O group serotypes or lipopolysaccharide-associated antigens. Additionally, some of these antigens are separated from bacterial cell walls or wall fragments. The invention also encompasses a composition containing hyperimmune material, along with its uses.

Career Highlights

Grant Thomas Rawlin is associated with Immuron Limited, where he applies his expertise in developing innovative solutions for health challenges. His work has been instrumental in advancing the understanding and treatment of enteric diseases.

Collaborations

Rawlin has collaborated with esteemed colleagues such as Roy Michael Robins-Browne and Gottfried Lichti, contributing to the collective knowledge and advancements in his field.

Conclusion

Grant Thomas Rawlin's innovative work in the treatment of enteric bacterial infections showcases his dedication to improving public health. His contributions through patents and collaborations highlight the importance of research and development in combating infectious diseases.